We are continuously working to consolidate our project pipeline to ensure depth and sustainability over time.

NeuroNova has two projects in phase I/II clinical trials. In addition, NeuroNova has projects in late stage preclinical development. Our rapidly advancing pipeline focuses on areas of high unmet medical need in neurodegenerative diseases.